FBRX   $4.73  5.11% Market Closed

Forte Biosciences Inc
Total Cash 24.50M
totalCashPerShare 16.778
EBITDA
Total Debt 0.00
quickRatio 2.687
currentRatio 2.82
Total Revenue
debtToEquity
Revenue/Share
ROA -0.81247
ROE -1.70907
grossProfits
freeCashflow -18.24M
operatingCashflow -30.63M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -17.76M
forwardPE -0.25507396
floatShares 882.26K
sharesOutstanding 1.46M
sharesShort 3.26K
sharesShortPriorMonth 5.74K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.56%
Short Ratio help_outline 0.25%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 11.635
Price To Book help_outline 0.40
earningsQuarterlyGrowth
netIncomeToCommon -35.76M
trailingEps -17.25%
forwardEps -18.25%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -7.12 3Q 2024
institutionsCount 35
lastUpdated Oct. 16, 2024, 9:49 p.m.